Found: 22
Select item for more details and to access through your institution.
Targeted treatment of immune thrombocytopenia in CTLA‐4 insufficiency: a case report.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. e42, doi. 10.1111/bjh.17866
- By:
- Publication type:
- Article
The use of dupilumab in severe atopic dermatitis during pregnancy: a case report.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2022, v. 18, n. 1, p. 1, doi. 10.1186/s13223-022-00650-w
- By:
- Publication type:
- Article
Malignancy and immune disorders in patients with hereditary angioedema.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2021, v. 17, n. 1, p. 1, doi. 10.1186/s13223-021-00621-7
- By:
- Publication type:
- Article
The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?
- Published in:
- Allergy, Asthma & Clinical Immunology, 2021, v. 17, n. 1, p. 1, doi. 10.1186/s13223-021-00607-5
- By:
- Publication type:
- Article
Impact of lanadelumab in hereditary angioedema: a case series of 12 patients in Canada.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Selective cannabis strain allergy in a patient presenting with a local allergic reaction.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2021, v. 17, n. 1, p. 1, doi. 10.1186/s13223-021-00552-3
- By:
- Publication type:
- Article
Natural history, prognostic factors and patient perceived response to treatment in chronic spontaneous urticaria.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2020, v. 16, n. 1, p. 1, doi. 10.1186/s13223-020-00459-5
- By:
- Publication type:
- Article
Correction to: The International/Canadian Hereditary Angioedema Guideline.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The International/Canadian Hereditary Angioedema Guideline.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2019, v. 15, n. 1, p. N.PAG, doi. 10.1186/s13223-019-0376-8
- By:
- Publication type:
- Article
Review of cold-induced urticaria characteristics, diagnosis and management in a Western Canadian allergy practice.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2018, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13223-018-0310-5
- By:
- Publication type:
- Article
The diagnosis of hereditary angioedema with C1 inhibitor deficiency: a survey of Canadian physicians and laboratories.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2018, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13223-018-0307-0
- By:
- Publication type:
- Article
Urticaria and angioedema.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2018, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13223-018-0288-z
- By:
- Publication type:
- Article
BC Society of Allergy and Immunology statement on the climate crisis.
- Published in:
- British Columbia Medical Journal, 2021, v. 63, n. 7, p. 271
- By:
- Publication type:
- Article
Expanding the molecular and phenotypic spectrum of CTLA‐4 insufficiency.
- Published in:
- Pediatric Allergy & Immunology, 2024, v. 35, n. 2, p. 1, doi. 10.1111/pai.14077
- By:
- Publication type:
- Article
Case series: expanding diagnostic markers in postorgasmic illness syndrome.
- Published in:
- Sexual Medicine, 2023, v. 11, n. 2, p. 1, doi. 10.1093/sexmed/qfac021
- By:
- Publication type:
- Article
Media as a Generational Object: Investigating the Role of Media Consumption on Generational Identity.
- Published in:
- Security & Social Order Strategic Studies, 2020, v. 8, n. 3, p. 9, doi. 10.22108/srspi.2020.121075.1491
- By:
- Publication type:
- Article
REVIEW Open Access Urticaria and angioedema.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2011, v. 7, n. S1, p. 1, doi. 10.1186/1710-1492-7-S1-S9
- By:
- Publication type:
- Article
Cannabis‐related allergies: An international overview and consensus recommendations.
- Published in:
- Allergy, 2022, v. 77, n. 7, p. 2038, doi. 10.1111/all.15237
- By:
- Publication type:
- Article
Real-world outcomes of patients with hereditary angioedema with normal C1-inhibitor function and patients with idiopathic angioedema of unknown etiology in Canada.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2024, v. 20, n. 1, p. 1, doi. 10.1186/s13223-024-00910-x
- By:
- Publication type:
- Article
Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2023, v. 19, n. 1, p. 1, doi. 10.1186/s13223-023-00805-3
- By:
- Publication type:
- Article
Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2022, v. 18, n. 1, p. 1, doi. 10.1186/s13223-022-00709-8
- By:
- Publication type:
- Article
A Patient Charter for Chronic Urticaria.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 1, p. 14, doi. 10.1007/s12325-023-02724-6
- By:
- Publication type:
- Article